A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromes
- 6 July 2023
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (10) , e30537
Abstract
Background: At least 5%–10% of malignancies occur secondary to an underlying cancer predisposition syndrome (CPS). For these families, cancer surveillance is recommended with the goal of identifying malignancy earlier, in a presumably more curable form. Surveillance protocols, including imaging studies, bloodwork, and procedures, can be complex and differ based on age, gender, and syndrome, which adversely affect adherence. Mobile health (mHealth) applications (apps) have been utilized in oncology and could help to facilitate adherence to cancer surveillance protocols.Methods: Applying a user‐centered mobile app design approach, patients with a CPS and/or primary caregivers were interviewed to identify current methods for care management and barriers to compliance with recommended surveillance protocols. Broad themes from these interviews informed the design of the mobile app, HomeTown, which was subsequently evaluated by usability experts. The design was then converted into software code in phases, evaluated by patients and caregivers in an iterative fashion. User population growth and app usage data were assessed.Results: Common themes identified included general distress surrounding surveillance protocol scheduling and results, difficulty remembering medical history, assembling a care team, and seeking resources for self‐education. These themes were translated into specific functional app features, including push reminders, syndrome‐specific surveillance recommendations, ability to annotate visits and results, storage of medical histories, and links to reliable educational resources.Conclusions: Families with CPS demonstrate a desire for mHealth tools to facilitate adherence to cancer surveillance protocols, reduce related distress, relay medical information, and provide educational resources. HomeTown may be a useful tool for engaging this patient population.Keywords
All Related Versions
Funding Information
- Georgia Clinical and Translational Science Alliance (UL1TR002378)
- Children's Healthcare of Atlanta
This publication has 22 references indexed in Scilit:
- Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in ChildhoodClinical Cancer Research, 2017
- Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson JrClinical Cancer Research, 2017
- Cancer Screening Recommendations for Individuals with Li-Fraumeni SyndromeClinical Cancer Research, 2017
- Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid TumorsJAMA Oncology, 2016
- Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid TumorsJAMA Oncology, 2016
- Germline Mutations in Predisposition Genes in Pediatric CancerNew England Journal of Medicine, 2015
- An Internal Performance Assessment of CancerGene Connect: An Electronic Tool to Streamline, Measure and Improve the Genetic Counseling ProcessJournal of Genetic Counseling, 2014
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational studyThe Lancet Oncology, 2011
- Pediatric endocrine screening for von Hippel-Lindau disease: Benefits and the challenge of complianceJournal of Endocrinological Investigation, 2010
- Hereditary Cancer Predisposition SyndromesJournal of Clinical Oncology, 2005